Wockhardt Share price

Q: How to buy Wockhardt Share at Choice?

To buy Wockhardt stocks , log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Wockhardt, choose your preferred order type, and place the trade.

WOCKPHARMA

Healthcare Large Cap

1926

18.40 (0.96%)

NSE

BSE

Last updated on 16 Jun, 2026 | 15:30 IST

BuySell

Today's High

1943.40

Today's Low

1904.90

52 Week Low

1086.70

52 Week High

2422.30

Wockhardt Chart

ChartIQ

TradingView

Wockhardt Share Key Metrics

Volume

7.14 L

Market Cap

30997.01 CR

LTQ@LTP

3@1926.00

ATP

1920.81

Var Margin

100 %

Circuit Range

1526.1-2289.1

Delivery %

37.2 %

Value

137.16 CR

ASM/GSM

No

Market Lot

1

Summary

Wockhardt share price is ₹1926 as of 16 Jun, 2026. The stock Wockhardt intraday movement has stayed between ₹1904.90 and ₹1943.40, while on a 52-week basis,Wockhardt price 52 week high is ₹2422.30 & its 52 week low is ₹1086.70.

In terms of trading activity, Wockhardt has recorded a volume of 714079 shares, The Wockhardt has a market cap of ₹162492169 CR. The stock’s Average Traded Price (ATP) stands at ₹1920.81, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 3 @ ₹1926.00.

Wockhardt operates within a circuit range of ₹1526.10 – ₹2289.10, with a Value of ₹137.16 CR. The Delivery Percentage for the day is 37.2%. Additionally, Wockhardt currently falls under the No framework, and trades with a market lot size of 1.

Wockhardt Fundamentals

P/E Ratio

145.53

P/B Ratio

6.27

Div. Yield

0

Sector P/E

71.29

Sector P/B

3.05

Sec. Div. Yield

0.54

Wockhardt Resistance and Support

Pivot 1921.47

Resistance

First Resistance

1954.14

Second Resistance

2000.67

Third Resistance

2033.34

Support

First Support

1874.94

Second Support

1842.27

Third Support

1795.74

Wockhardt Shareholding Pattern

2016-17
2018-19
2019-20
2020-21
2021-22
2022-23
2023-24
2024-25
2025-26
2026-27

Total Promoters

Segment

Percent

Total Promoters

49.08%

Mutual Fund

8.12%

Insurance

0.06%

Foreign Institutional Investors

7.08%

Domestic Institutional Investors

2.81%

Retail

32.84%

Others

0.01%

Total Promoters

MAR '26

49.08%

Wockhardt Corporate Actions

Date	Agenda
2026-05-04	Audited Results & Others
2026-02-10	Quarterly Results
2025-11-03	Quarterly Results
2025-08-08	Quarterly Results
2025-05-29	Audited Results & Fund Raising
2025-02-07	Quarterly Results

Wockhardt News

Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Wockhardt Limited will hold an Investor Meet on June 4, 2026, at NSE Exchange Plaza, BKC. The meet will include presentations on strategic overview, Zaynich US, and Zaynich India businesses, followed by a Q&A session with key management personnel.

Jun 01 2026 20:31:54

Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Wockhardt received U.S. FDA approval for ZAYNICH™, a novel intravenous antibiotic used to treat complicated urinary tract infections. This approval provides a new option for patients with multidrug-resistant Gram-negative bacteria.

May 30 2026 18:21:39

Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Wockhardt has received marketing authorization from the Central Drugs Standard Control Organisation (CDSCO) for its breakthrough antibiotic, Zaynich® (Zidebactam/Cefepime). This approval targets complicated urinary tract infections including pyelonephritis with Gram-negative bacteremia.

May 28 2026 09:16:15

Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Credit Rating

ICRA Limited has upgraded Wockhardt's credit ratings. Long-term instruments are now rated 'A- (Stable)' and short-term instruments 'A2+'. This upgrade reflects the company's improved financial performance and market position.

May 21 2026 14:39:33

Name	Position
Rashmi Mamtura	Company Secretary & Compliance Officer
Habil Khorakiwala	Chairman

Wockhardt Similar Stocks

JB Chemicals & Pharmaceuticals Ltd.

2189.00

-28.80 (1.30%)

Glaxosmithkline Pharmaceuticals Ltd.

2197.10

74.60 (3.51%)

Global Health Ltd.

1242.20

22.30 (1.83%)

Emcure Pharmaceuticals Ltd.

1733.00

27.40 (1.61%)

Krishna Institute of Medical Sciences Ltd

779.90

10.05 (1.31%)

Dr. Lal Pathlabs Ltd.

1645.00

29.00 (1.79%)

Sai Life Sciences Ltd.

1201.00

-6.90 (0.57%)

Acutaas Chemicals Ltd.

2979.00

-117.70 (3.80%)

Neuland Laboratories Ltd.

16709.00

-347.00 (2.03%)

Piramal Pharma Ltd.

163.79

-3.41 (2.04%)

Wockhardt FAQs

The Buying Price of Wockhardt share is 1926 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Wockhardt stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Wockhardt, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Wockhardt shares is 145.53. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Wockhardt shares is 6.27. Useful to assess the stock's value relative to its book value.

To assess Wockhardt’s valuation compare Sector P/E, P/B which are 71.29 & 3.05 with sector averages, along with growth rates and financial metrics.

The Market Cap of Wockhardt is 30997.01 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Wockhardt share price is 2422.30 & 1086.70. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Wockhardt belongs to the Healthcare sector.